National Taiwan University, Taiwan
Complement C3a may be diagnostic of chronic hepatitis C and HCV-related HCC
Published in Lab Law Weekly, July 14th, 2006
"Although the significant risk factors for HCC are well known from epidemiological studies, diagnosis of this disease at an early stage is difficult, and HCC remains one of the leading causes of cancer death worldwide. Thus, to identify any useful HCC-related biomarkers is still a need," wrote I.N. Lee and colleagues, National Taiwan University.
"We performed SELDI-TOF MS to identify differentially expressed proteins in HCC serum using weak cation exchange protein chips. Protein characterization...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2006-07-14)
More Articles from Lab Law Weekly
- Delmarva Foundation, U.S.
Delmarva Foundation celebrates achievements of hospitals in 100,000 Lives Campaign - Enzo Biochem
Enzo Biochem reports results for third fiscal quarter - European Society for Human Reproduction and Embryology
Identity fraud a growing concern among clinics providing in vitro fertilization procedures - Healthcare Costs
Total knee replacement adverse outcome predictive index is developed - Human Genome Sciences
Human Genome Sciences completes transaction establishing CoGenesys as independent company - Insmed
Court dismisses unfair business practices lawsuit brought against Insmed - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
